Danielle R. Jacobsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Danielle R. Jacobsen has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Stephanie C. Eisenbarth
The Department Medicine, Division of Allergy and Immunology Northwestern University Feinberg School of Medicine Chicago Illinois USA
3 shared publications - Adam Williams
Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
2 shared publications David K. Stevenson
Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA 94305, USA
2 shared publications- Emily R. Siniscalco
Department of Immunobiology, Yale School of Medicine, New Haven, CT 06520, USA; Center for Human Immunobiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
2 shared publications - Ronald J. Wong
Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA, USA
2 shared publications - Aditi Verma
Centre for Neuroscience, Indian Institute of Science Bangalore India
1 shared publication
Latest Publications
- 28 January 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (3)
DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells
Patients with loss-of-function DOCK8 or dominant-negative STAT3 variants have hyper-IgE syndrome, although only DOCK8 deficiency consistently presents with elevated food-specific IgE and symptomatic allergy. We previously found in mice that DOCK8 restricts the differentiation of IL-13+ T follicular helper (Tfh13) cells that drive anaphylactic IgE, although the mechanisms were unclear. Here, we show that DOCK8 promotes STAT3 activity, which inhibits GATA3 in T cells. However, only patients with DOCK8, but not STAT3, deficiency had elevated Tfh13 cells. Cell-specific deletion of either Dock8 (T-Dock8−/−) or Stat3 (T-Stat3−/−) augmented peanut-specific IgE and Tfh13s when oral sensitization was promoted by adjuvants. However, the phenotypes diverged during adjuvant-free oral peanut exposure: only T-Dock8−/− mice developed Tfh13 cells and peanut-specific IgE, accompanied by reduced Foxp3+ Tregs. Treg depletion in T-Stat3−/− mice unmasked Tfh13 induction to oral antigen alone. Thus, DOCK8 and STAT3 cooperate to restrain Tfh13 differentiation to food allergens, and additional Treg impairment in DOCK8 deficiency allows for Tfh13 cell induction and allergy.
- 28 January 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (3)
DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells
Patients with loss-of-function DOCK8 or dominant-negative STAT3 variants have hyper-IgE syndrome, although only DOCK8 deficiency consistently presents with elevated food-specific IgE and symptomatic allergy. We previously found in mice that DOCK8 restricts the differentiation of IL-13+ T follicular helper (Tfh13) cells that drive anaphylactic IgE, although the mechanisms were unclear. Here, we show that DOCK8 promotes STAT3 activity, which inhibits GATA3 in T cells. However, only patients with DOCK8, but not STAT3, deficiency had elevated Tfh13 cells. Cell-specific deletion of either Dock8 (T-Dock8−/−) or Stat3 (T-Stat3−/−) augmented peanut-specific IgE and Tfh13s when oral sensitization was promoted by adjuvants. However, the phenotypes diverged during adjuvant-free oral peanut exposure: only T-Dock8−/− mice developed Tfh13 cells and peanut-specific IgE, accompanied by reduced Foxp3+ Tregs. Treg depletion in T-Stat3−/− mice unmasked Tfh13 induction to oral antigen alone. Thus, DOCK8 and STAT3 cooperate to restrain Tfh13 differentiation to food allergens, and additional Treg impairment in DOCK8 deficiency allows for Tfh13 cell induction and allergy.
- 7 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6760) , eadp0240
Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice
Food-specific immunoglobulin E (IgE) triggers life-threatening anaphylaxis; however, for unclear reasons, some people with food-specific IgE are asymptomatic upon allergen consumption. We studied strains of mice with different sensitivities to anaphylaxis when orally challenged with allergen to identify possible causes. In resistant C57BL/6 mice, intestinal goblet cells transported less food allergen than did anaphylaxis-susceptible strains, even before allergic sensitization. In a forward genetic screen, resistance was correlated with dipeptidase 1 ( Dpep1 ) variants. DPEP1 is expressed in intestinal epithelium and catabolizes leukotriene D 4 (LTD 4 ). Blocking DPEP1 with cilastatin, deleting Dpep1 , or administering LTD 4 orally enhanced allergen transport in resistant mice. Conversely, pretreatment of susceptible mice with a synthesis inhibitor, zileuton, abrogated allergen absorption and oral anaphylaxis, indicating that this could be an approach to treating food allergy.
- 7 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6760) , eadp0240
Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice
Food-specific immunoglobulin E (IgE) triggers life-threatening anaphylaxis; however, for unclear reasons, some people with food-specific IgE are asymptomatic upon allergen consumption. We studied strains of mice with different sensitivities to anaphylaxis when orally challenged with allergen to identify possible causes. In resistant C57BL/6 mice, intestinal goblet cells transported less food allergen than did anaphylaxis-susceptible strains, even before allergic sensitization. In a forward genetic screen, resistance was correlated with dipeptidase 1 ( Dpep1 ) variants. DPEP1 is expressed in intestinal epithelium and catabolizes leukotriene D 4 (LTD 4 ). Blocking DPEP1 with cilastatin, deleting Dpep1 , or administering LTD 4 orally enhanced allergen transport in resistant mice. Conversely, pretreatment of susceptible mice with a synthesis inhibitor, zileuton, abrogated allergen absorption and oral anaphylaxis, indicating that this could be an approach to treating food allergy.
- 2 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (107) , eady4136
Tolerance requires diversity (of antigen presenting cells)
Multiple APC subsets cooperate to induce regulatory T cells in the gut.
- 2 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (107) , eady4136
Tolerance requires diversity (of antigen presenting cells)
Multiple APC subsets cooperate to induce regulatory T cells in the gut.
- Top Cited Papers
- 5 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (592)
Integrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset
Peripheral blood dynamics in the 100 days before delivery reveal a transition from pregnancy maintenance to prelabor biology.
- 5 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (592)
Top Cited PapersIntegrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset
Peripheral blood dynamics in the 100 days before delivery reveal a transition from pregnancy maintenance to prelabor biology.
- 20 December 2019
- Published by Wiley in Acta Paediatrica
- Vol. 109 (8) , 1551-1559
Low‐dose lipopolysaccharide exposure can increase in vivo bilirubin production rates in newborn mice
Aim Neonatal hemolysis increases bilirubin production rates, which can then lead to severe hyperbilirubinemia and bilirubin neurotoxicity. During hemolysis, heme is degraded by heme oxygenase (HO), which can be induced under stress conditions. It is known that neonatal sepsis is a risk factor for hemolysis and severe hyperbilirubinemia. Here, we evaluated if an exposure to lipopolysaccharide (LPS) to induce sepsis can upregulate HO‐1, further increasing in vivo bilirubin production rates in mouse pups under heme loads. Methods 3‐day‐old pups were given LPS (1250 μg/kg) or saline (controls). Liver HO enzyme activity, HO‐1 mRNA, and HO‐1 protein were measured post‐LPS exposure. We then assessed the effects of LPS treatment on in vivo bilirubin production rates after heme loading. Results Liver HO activity significantly increased (142%) over controls 24 hours after treatment with LPS (1250 μg/kg) without mortality. Liver HO‐1 mRNA was significantly upregulated 2.47‐fold at 24 hours post‐LPS administration, while liver HO‐1 protein increased 1.29‐fold 24 hours post‐LPS treatment. After heme loading, pups exposed to LPS had significantly higher bilirubin production rates (1.30‐fold) compared with age‐matched, saline‐treated controls. Conclusion Low‐dose LPS treatment can upregulate liver HO‐1 expression and may underlie the severe hyperbilirubinemia seen in septic infants, particularly when undergoing hemolysis.
- 20 December 2019
- Published by Wiley in Acta Paediatrica
- Vol. 109 (8) , 1551-1559
Low‐dose lipopolysaccharide exposure can increase in vivo bilirubin production rates in newborn mice
Aim Neonatal hemolysis increases bilirubin production rates, which can then lead to severe hyperbilirubinemia and bilirubin neurotoxicity. During hemolysis, heme is degraded by heme oxygenase (HO), which can be induced under stress conditions. It is known that neonatal sepsis is a risk factor for hemolysis and severe hyperbilirubinemia. Here, we evaluated if an exposure to lipopolysaccharide (LPS) to induce sepsis can upregulate HO‐1, further increasing in vivo bilirubin production rates in mouse pups under heme loads. Methods 3‐day‐old pups were given LPS (1250 μg/kg) or saline (controls). Liver HO enzyme activity, HO‐1 mRNA, and HO‐1 protein were measured post‐LPS exposure. We then assessed the effects of LPS treatment on in vivo bilirubin production rates after heme loading. Results Liver HO activity significantly increased (142%) over controls 24 hours after treatment with LPS (1250 μg/kg) without mortality. Liver HO‐1 mRNA was significantly upregulated 2.47‐fold at 24 hours post‐LPS administration, while liver HO‐1 protein increased 1.29‐fold 24 hours post‐LPS treatment. After heme loading, pups exposed to LPS had significantly higher bilirubin production rates (1.30‐fold) compared with age‐matched, saline‐treated controls. Conclusion Low‐dose LPS treatment can upregulate liver HO‐1 expression and may underlie the severe hyperbilirubinemia seen in septic infants, particularly when undergoing hemolysis.
- Open Access
- 30 October 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Colorimetric Assay Reports on Acyl Carrier Protein Interactions
The ability to produce new molecules of potential pharmaceutical relevance via combinatorial biosynthesis hinges on improving our understanding of acyl-carrier protein (ACP)-protein interactions. However, the weak and transient nature of these interactions makes them difficult to study using traditional spectroscopic approaches. Herein we report that converting the terminal thiol of the E. coli ACP 4′-phosphopantetheine arm into a mixed disulfide with 2-nitro-5-thiobenzoate ion (TNB−) activates this site to form a selective covalent cross-link with the active site cysteine of a cognate ketoacyl synthase (KS). The concomitant release of TNB2−, which absorbs at 412 nm, provides a visual and quantitative measure of mechanistically relevant ACP-KS interactions. The colorimetric assay can propel the engineering of biosynthetic routes to novel chemical diversity by providing a high-throughput screen for functional hybrid ACP-KS partnerships as well as the discovery of novel antimicrobial agents by enabling the rapid identification of small molecule inhibitors of ACP-KS interactions.
- 30 October 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Open AccessColorimetric Assay Reports on Acyl Carrier Protein Interactions
The ability to produce new molecules of potential pharmaceutical relevance via combinatorial biosynthesis hinges on improving our understanding of acyl-carrier protein (ACP)-protein interactions. However, the weak and transient nature of these interactions makes them difficult to study using traditional spectroscopic approaches. Herein we report that converting the terminal thiol of the E. coli ACP 4′-phosphopantetheine arm into a mixed disulfide with 2-nitro-5-thiobenzoate ion (TNB−) activates this site to form a selective covalent cross-link with the active site cysteine of a cognate ketoacyl synthase (KS). The concomitant release of TNB2−, which absorbs at 412 nm, provides a visual and quantitative measure of mechanistically relevant ACP-KS interactions. The colorimetric assay can propel the engineering of biosynthetic routes to novel chemical diversity by providing a high-throughput screen for functional hybrid ACP-KS partnerships as well as the discovery of novel antimicrobial agents by enabling the rapid identification of small molecule inhibitors of ACP-KS interactions.